Clinical Trial
Europe’s first-ever clinical study into the effect of a nutritional supplement on fertility
Clinical Trial
Pillar & Mark Whitney's Approach
After a three year period investigating reproductive health and the potential causes of infertility, Pillar commissioned an independent clinical examination into their approach – can nutritional intervention improve male and female fertility? Whilst their proposed treatment plan was built on the foundations of previous hypothesis and research, they needed to show that their evolved approach would bring improvements in a clinical setting.
They worked with twenty couples, forty individuals, with an average age of thirty-seven, all diagnosed as infertile in accordance with the guidelines set by the World Health Organisation. In working with these individuals over a ninety day period, they made adjustments to their dietary intake, their lifestyle and introduced a nutritional supplement into their daily routine.
The Lead Researchers Conclusion stated,
"pre-Conceive combined with nutritional advice improves the levels of key fertility and nutritional parameters.”
Male Results
- 85% of men improved their Progressive Motility
- 79% of men improved their Total Motility
- 71% of men improved their Overall Sperm Count
- 81% of men showed improvements in the DNA of their sperm cells
- 1 in 2 men improved their antioxidant marker Superoxide Dismutase (Protects Sperm Cells)
- 82% of men improved the antioxidant marker Glutathione Peroxidase (Associated with sperm count, mobility and viability)
- 84.6% of men had improved Vitamin D3 levels
- 71.4% of men improved their Folate levels
- 79.% of men improved their B12 levels
- 66% of men improve their morphology (lower the amount of abnormalities)
Female Results
- 60% of women improved in the antioxidant marker Superoxide Dismutase (Protects follicle and egg quality)
- 60% of women improved the antioxidant marker Glutathione Peroxidase (Improves fertilisation and conception rates)
- 82% of women improved their Vitamin D3 levels
- 45% of women had improved Folate levels
- 82% of women had improved B12 levels
- 71.43% of women had improved AMH levels
M.B., Ch.B., L.R.C.P., M.R.C.S., M.F. Hom., F.C.O.H.
Dr. David Smallbone
A former President of the Food & Health Section of the Royal Society of Medicine (UK), after reviewing the trial data concluded that,
"In conclusion, I believe the report favourably shows that providing adequate nutritional materials can and does influence the body systems. It becomes apparent that important systems, such as the endocrine system, can be affected by correct nutrition but it needs time and six months is not an unreasonable amount of time, especially when several years of nutritional abuse lie behind the problem. Unless the nutritional requirements of the body are specifically catered for, it is highly unlikely that full health can be expected. pre-Conceive consciously provides those specific nutritional needs for full fertility health to be achieved. It may be that, in most cases, very little else is required - except time. It is important that when fertilisation ensues, that the nutritional support is maintained for full potential development of the foetus."
"The Anti-Mullerian Hormone (AMH) is a general indicator of the state of ovarian reserve in women. It appears that many women in the group were below, or close to, the lower threshold levels. It appears to be very much age related and very difficult to accurately quantify. It appears that 71.43% of women had an improvement in their levels over the period. In my opinion, Pillar Healthcare’s pre-Conceive product is the best available for a single dose material.”